聯合光電(300691.SZ):激光投影鏡頭、VR/AR一體機等產品已廣泛應用在激光電視、智能投影、視訊會議等領域
格隆匯3月12日丨聯合光電(300691.SZ)於近期投資者關係活動表示,在新型顯示領域,公司主要產品包括激光投影鏡頭、VR/AR一體機等,已廣泛應用在激光電視、智能投影、工程投影、視訊會議、增強現實與虛擬現實等領域。此外,公司2024年開拓了AI眼鏡業務,目前公司AI眼鏡的產能儲備處在結合客戶需求、產品成熟度逐步籌備產能爬升的節點,總體出貨可以滿足目前客戶需求,該產品目前業務量較小,對公司業績影響有限。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.